Product Information
CARBIDOPA 25 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6336 per EA under NDC 59651014601. Its NADAC has been published 323 times since Apr 22, 2020.
Strength
25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651014601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA211055On Market Since
10/21/2019
Price Statistics
The NADAC for CARBIDOPA 25 MG TABLET has been published 323 times since Apr 22, 2020, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6336 per EA |
|---|---|
| All-time high | $4.7804 (May 13, 2020) |
| All-time low | $0.6336 (Jun 17, 2026) |
| 52-week high | $0.7439 |
| 52-week low | $0.6336 |
| Median price | $1.1365 |
| Average price | $1.6730 |
| Largest weekly change | -60.1% (Feb 23, 2022) |
| Weeks tracked | 323 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA 25 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6336 per EA (NDC 59651014601), effective Jun 24, 2026.
How has the price of CARBIDOPA 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBIDOPA 25 MG TABLET has declined 86.7%. It has been tracked across 323 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for CARBIDOPA 25 MG TABLET?
Since Apr 22, 2020, the NADAC for CARBIDOPA 25 MG TABLET has ranged from a low of $0.6336 (Jun 17, 2026) to a high of $4.7804 (May 13, 2020), with a median of $1.1365 per EA.
Are there cheaper alternatives to CARBIDOPA 25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA 25 MG TABLET, but none are currently priced below it.
Who manufactures CARBIDOPA 25 MG TABLET?
CARBIDOPA 25 MG TABLET (NDC 59651014601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification